Page 4 - Timothyp Herbert News Today

Shares of Inspire Medical Systems, Inc. (NYSE:INSP – Get Rating) have received a consensus recommendation of “Buy” from the ten research firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1-year price target […]

Stock analysts at Truist Financial began coverage on shares of Inspire Medical Systems (NYSE:INSP – Get Rating) in a research report issued on Tuesday, The Fly reports. The firm set a “buy” rating on the stock. Several other brokerages also recently issued reports on INSP. Wolfe Research initiated coverage on shares of Inspire Medical Systems […]

Inspire Medical Systems, Inc. (NYSE:INSP – Get Rating) has been assigned a consensus rating of “Buy” from the eight brokerages that are presently covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average twelve-month target price among […]

Strs Ohio boosted its stake in Inspire Medical Systems, Inc. (NYSE:INSP – Get Rating) by 18.4% during the 4th quarter, HoldingsChannel reports. The fund owned 46,300 shares of the company’s stock after acquiring an additional 7,200 shares during the quarter. Strs Ohio’s holdings in Inspire Medical Systems were worth $10,651,000 as of its most recent […]

Wall Street brokerages expect that Inspire Medical Systems, Inc. (NYSE:INSP – Get Rating) will report ($0.73) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Five analysts have issued estimates for Inspire Medical Systems’ earnings, with estimates ranging from ($0.90) to ($0.47). Inspire Medical Systems posted earnings of ($0.60) per […]

INSP earnings call for the period ending September 30, 2021.

Markets In a report issued on April 26, Richard Newitter from Leerink Partners maintained a Buy rating on Inspire Medical Systems (INSP – Research Report). The company’s shares closed last Wednesday at $242.23, close to its 52-week high of $252.25. According to TipRanks.com, Newitter is a 5-star analyst with an average return of 28.6% and a 71.1% success rate. Newitter covers the Healthcare sector, focusing on stocks such as Zimmer Biomet Holdings, Organogenesis Holdings, and Intuitive Sur...